If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,636.00    54.00 (1.18%)
Bid:
4,626.00
Ask:
4,627.00
Spread: 1.00 (0.022%)
Market Cap: £100.10b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Admission to Trading

11 May 2026 11:45

RNS Number : 8133D
British American Tobacco PLC
11 May 2026
 

NOTIFICATION OF ADMISSION TO TRADING OF TRANSFERABLE SECURITIES

The following transferrable securities issued by B.A.T. International Finance p.l.c. (LEI: 21380041YBGOQDFAC823) (the "Issuer") have today (11 May 2026) been admitted to trading on the main market of the London Stock Exchange plc:

- €500,000,000 3.375 per cent. Guaranteed Notes due 2029 (ISIN: XS3374290412) (the "Notes")

The Notes are issued pursuant to the base prospectus dated 18 March 2026 (the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T. Netherlands Finance B.V. and B.A.T Capital Corporation (each as Issuers of Senior Notes) and British American Tobacco p.l.c. and each of the Issuers of Senior Notes (except where it is the relevant Issuer) (as Guarantors of the Senior Notes) read together with the Final Terms dated 7 May 2026 relating to the Notes (the "Final Terms").

Full information on the Issuer and the offer of the Notes is only available on the basis of the Prospectus, read together with the Final Terms.

 

The Prospectus and Final Terms have been published on the website of the London Stock Exchange through a regulatory information service (https://www.londonstockexchange.com/news?tab=news-explorer).

 

Enquiries

Media Centre

press_office@bat.com | @BATplc

Investor Relations 

Victoria Buxton | IR_team@bat.com

11 May 2026

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms (when read together with the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

The Notes have not been registered under the Securities Act or any relevant securities laws of any state of the United States, and may not be offered or sold in the United States absent registration or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ADMUAARRNSUVAAR
Date   Source Headline
5th Mar 202612:30 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:00 amRNSBAT to Present at CAGNY; Reaffirming FY26 Guidance
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20265:00 pmRNSDirector/PDMR Shareholding
17th Feb 202612:30 pmRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20266:00 pmRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20262:00 pmRNSAnnual Financial Report
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:30 amRNSShare Buyback Programme
12th Feb 20267:05 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSPreliminary Results
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20269:00 amRNSBoard Update - Chair Extension and SID Appointment
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:00 pmRNSHolding(s) in Company
9th Feb 202611:00 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 202611:10 amRNSDirector/PDMR Shareholding
6th Feb 202611:05 amRNSDirector/PDMR Shareholding
6th Feb 202611:00 amRNSDirector/PDMR Shareholding
6th Feb 202610:45 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202612:15 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20264:30 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.